Mount Sinai Braman Comprehensive Cancer Center

Clinical research site in Miami Beach, Florida

Part of Mount Sinai

As of July 2026, 4 paid clinical trials are recruiting at Mount Sinai Braman Comprehensive Cancer Center in Miami Beach, Florida. Active studies at this site cover conditions such as Fallopian Tube Neoplasms, Neoplasm Metastasis and Ovarian Neoplasms. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.

Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: July 19, 2026.

Recruiting clinical trials at Mount Sinai Braman Comprehensive Cancer Center (4)

A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer

for Ovarian Neoplasms

88 locations incl. Birmingham

Sponsor: Eli Lilly and Company

Sex: All·Age: 18+

Code: NCT07213804·Phase 3·Recruiting·Listed Oct 2025

Apply to this trial

A Clinical Study of Zilovertamab Vedotin (MK-2140) Plus Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Polatuzumab Vedotin Plus R-CHP in People With Diffuse Large B-cell Lymphoma (DLBCL) (MK-2140-011/waveLINE-011)

for Lymphoma, Large B-Cell, Diffuse

71 locations incl. Mobile

Sponsor: Merck Sharp & Dohme LLC

Sex: All·Age: 18+

Code: NCT06890884·Phase 2·Recruiting·Listed Mar 2025

Apply to this trial

Long-term Safety and Efficacy Extension Study for Participants With Advanced Tumors Who Are Currently on Treatment or in Follow-up in a Pembrolizumab (MK-3475) Study (MK-3475-587/KEYNOTE-587)

for Solid Tumors

43 locations incl. Tucson

Sponsor: Merck Sharp & Dohme LLC

Sex: All·Age: 18+

Code: NCT03486873·Phase 3·Recruiting·Listed Apr 2018

Apply to this trial

A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) Versus Pembrolizumab Alone as Treatment in Participants With Mismatch Repair Proficient Endometrial Cancer (MK-2870-033/TroFuse-033/GOG-3119/ENGOT-en29)

for Endometrial Cancer

43 locations incl. Mobile

Sponsor: Merck Sharp & Dohme LLC

Sex: Female·Age: 18+

Code: NCT06952504·Phase 3·Recruiting·Listed May 2025

Apply to this trial

More research sites in Miami Beach

Mount Sinai Medical Center (34 trials)
Mount Sinai Comprehensive Cancer Center (14 trials)
Mount Sinai Cancer Center (6 trials)
Mount Sinai Medical Center of Florida (4 trials)
Quantum Clinical Trials (3 trials)
CZ Rheumatology (2 trials)
Mount Sinai Medical Center Comprehensive Cancer Center (2 trials)
335 (1 trial)
Ascentage Investigative Site (1 trial)
Broward Research Center (1 trial)

Explore more

Paid clinical trials in Miami Beach, FL · Florida clinical trials